Single-cell genomic variation induced by mutational processes in cancer
Tyler Funnell,Ciara H O'Flanagan,Marc J Williams,Andrew McPherson,Steven McKinney,Farhia Kabeer,Hakwoo Lee,Sohrab Salehi,Ignacio Vázquez-García,Hongyu Shi,Emily Leventhal,Tehmina Masud,Peter Eirew,Damian Yap,Allen W Zhang,Jamie L P Lim,Beixi Wang,Jazmine Brimhall,Justina Biele,Jerome Ting,Vinci Au,Michael Van Vliet,Yi Fei Liu,Sean Beatty,Daniel Lai,Jenifer Pham,Diljot Grewal,Douglas Abrams,Eliyahu Havasov,Samantha Leung,Viktoria Bojilova,Richard A Moore,Nicole Rusk,Florian Uhlitz,Nicholas Ceglia,Adam C Weiner,Elena Zaikova,J Maxwell Douglas,Dmitriy Zamarin,Britta Weigelt,Sarah H Kim,Arnaud Da Cruz Paula,Jorge S Reis-Filho,Spencer D Martin,Yangguang Li,Hong Xu,Teresa Ruiz de Algara,So Ra Lee,Viviana Cerda Llanos,David G Huntsman,Jessica N McAlpine,IMAXT Consortium,Sohrab P Shah,Samuel Aparicio,Gregory J Hannon,Georgia Battistoni,Dario Bressan,Ian G Cannell,Hannah Casbolt,Cristina Jauset,Tatjana Kovačević,Claire M Mulvey,Fiona Nugent,Marta Paez Ribes,Isabella Pearson,Fatime Qosaj,Kirsty Sawicka,Sophia A Wild,Elena Williams,Emma Laks,Austin Smith,Andrew Roth,Shankar Balasubramanian,Maximilian Lee,Bernd Bodenmiller,Marcel Burger,Laura Kuett,Sandra Tietscher,Jonas Windhager,Edward S Boyden,Shahar Alon,Yi Cui,Amauche Emenari,Daniel R Goodwin,Emmanouil D Karagiannis,Anubhav Sinha,Asmamaw T Wassie,Carlos Caldas,Alejandra Bruna,Maurizio Callari,Wendy Greenwood,Giulia Lerda,Yaniv Eyal-Lubling,Oscar M Rueda,Abigail Shea,Owen Harris,Robby Becker,Flaminia Grimaldo,Suvi Harris,Sara Lisa Vogl,Johanna A Joyce,Spencer S Watson,Simon Tavare,Khanh N Dinh,Eyal Fisher,Russell Kunes,Nicholas A Walton,Mohammed Al Sa'd,Nick Chornay,Ali Dariush,Eduardo A González-Solares,Carlos González-Fernández,Aybüke Küpcü Yoldaş,Neil Miller,Xiaowei Zhuang,Jean Fan,Hsuan Lee,Leonardo A Sepúlveda,Chenglong Xia,Pu Zheng
DOI: https://doi.org/10.1038/s41586-022-05249-0
IF: 64.8
Nature
Abstract:How cell-to-cell copy number alterations that underpin genomic instability1 in human cancers drive genomic and phenotypic variation, and consequently the evolution of cancer2, remains understudied. Here, by applying scaled single-cell whole-genome sequencing3 to wild-type, TP53-deficient and TP53-deficient;BRCA1-deficient or TP53-deficient;BRCA2-deficient mammary epithelial cells (13,818 genomes), and to primary triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSC) cells (22,057 genomes), we identify three distinct 'foreground' mutational patterns that are defined by cell-to-cell structural variation. Cell- and clone-specific high-level amplifications, parallel haplotype-specific copy number alterations and copy number segment length variation (serrate structural variations) had measurable phenotypic and evolutionary consequences. In TNBC and HGSC, clone-specific high-level amplifications in known oncogenes were highly prevalent in tumours bearing fold-back inversions, relative to tumours with homologous recombination deficiency, and were associated with increased clone-to-clone phenotypic variation. Parallel haplotype-specific alterations were also commonly observed, leading to phylogenetic evolutionary diversity and clone-specific mono-allelic expression. Serrate variants were increased in tumours with fold-back inversions and were highly correlated with increased genomic diversity of cellular populations. Together, our findings show that cell-to-cell structural variation contributes to the origins of phenotypic and evolutionary diversity in TNBC and HGSC, and provide insight into the genomic and mutational states of individual cancer cells.